Published in Hospital Business Week, May 18th, 2008
"Central SVC contrast injection can decrease the contrast volume by 50% while maintaining coronary attenuation similar to that of peripheral IV injection. This approach has potential in reducing the contrast volume on coronary MDCT angiography studies and therefore the risk of contrast-induced nephropathy in certain high-risk patients,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.